# Special Edition: What's Next—Cortisol, Metabolism & Future Innovation, Part 4

Page: https://stenobird.com/podcast/doc-updates-200053/special-edition-what-s-next-cortisol-metabolism-future-innovation-part-4
Text version: https://stenobird.com/podcast/doc-updates-200053/special-edition-what-s-next-cortisol-metabolism-future-innovation-part-4.md
Podcast: [DOC Updates](https://stenobird.com/podcast/doc-updates-200053)
Published: 2026-05-19T14:00:00+00:00
Episode link: https://diabetescoreupdate.libsyn.com/special-edition-whats-nextcortisol-metabolism-future-innovation-part-4
Audio file: https://traffic.libsyn.com/secure/diabetescoreupdate/Special_Edition_Hypercortisolism_in_Diabetes_and_Hypertension_May_2026.mp3?dest-id=159994
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/doc-updates-200053/episodes/special-edition-what-s-next-cortisol-metabolism-future-innovation-part-4
Duration seconds: 1626

## Resource

Is hypercortisolism the hidden culprit in a significant proportion of both difficult-to-treat diabetes and resistant hypertension? In part 4 of our special series, Dr. Neil Skolnik speaks with John Buse, MD to explore the effects of hypercortisolism, until just recently considered a vanishingly rare condition. This special episode is sponsored with support from Corcept . Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts , Amazon Music , Spotify , or your preferred podcast platform. Presented by: Neil Skolnik , MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John Buse , MD, The Verne S. Caviness Distinguished Professor and director of the Diabetes Center at the University of North Carolina at Chapel Hill School of Medicine, a past president of medicine & science at the American Diabetes Association (ADA), and recipient of the ADA Outstanding Achievement in Clinical Diabetes Research Award Selected references: Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes . Diabetes Care April 2025 Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment . Diabetes Care June 2025 MOMENTUM: Hypercortisolism Present in 1-in-4 with Resistant Hypertension . HCP Live March 2026

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/doc-updates-200053/episodes/special-edition-what-s-next-cortisol-metabolism-future-innovation-part-4/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/doc-updates-200053/special-edition-what-s-next-cortisol-metabolism-future-innovation-part-4.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.